Cargando…

Non-Coding Mutations in Urothelial Bladder Cancer: Biological and Clinical Relevance and Potential Utility as Biomarkers

Detalles Bibliográficos
Autores principales:	Yang, Alexander, Cross, Christopher N., Townsend, Jeffrey P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390591/ https://www.ncbi.nlm.nih.gov/pubmed/32793790 http://dx.doi.org/10.3233/BLC-200278

Ejemplares similares

Multiple primary malignancies: synchronous urothelial carcinoma of the bladder and adenocarcinoma of the colon
por: Queiroz, Rodolfo Mendes, et al.
Publicado: (2017)

Tropomyosins: Potential Biomarkers for Urothelial Bladder Cancer
por: Humayun-Zakaria, Nada, et al.
Publicado: (2019)

Isolated thyroid gland metastasis from bladder urothelial carcinoma: a rare description and literature analysis
por: Wang, Yan, et al.
Publicado: (2023)

A case of bladder urothelial carcinoma nested variant with invasion to the rectum treated with surgery and intraoperative radiotherapy
por: Yang, Yang, et al.
Publicado: (2023)

Large population-based study of upper tract urothelial carcinoma in China may provide further insight into the impact of bladder cancer on upper tract urothelial carcinoma’s prognosis in Chinese population
por: Zeng, Shuxiong, et al.
Publicado: (2022)

The Landscape of Long Non-Coding RNA Dysregulation and Clinical Relevance in Muscle Invasive Bladder Urothelial Carcinoma
por: Shen, Haotian, et al.
Publicado: (2019)

Urothelial Bladder Cancer Urinary Biomarkers
por: Noon, Aidan P, et al.
Publicado: (2014)

Comment on “Bladder Cancer–Specific Nuclear Matrix Proteins-4 May Be a Potential Biomarker for Non-Muscle-Invasive Bladder Cancer Detection”
por: Güllü Amuran, Gökçe
Publicado: (2019)

Expression signatures of exosomal long non-coding RNAs in urine serve as novel non-invasive biomarkers for diagnosis and recurrence prediction of bladder cancer
por: Zhan, Yao, et al.
Publicado: (2018)

Iron Overload and HFE Mutations: Are They Relevant in Cryptogenic Cirrhosis?
por: Castiella, Agustin
Publicado: (2012)

Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients
por: Alcaide, Eric, et al.
Publicado: (2022)

PLAUR as a Potential Biomarker Associated with Immune Infiltration in Bladder Urothelial Carcinoma
por: Liu, Mulin, et al.
Publicado: (2021)

Prioritizing potential circRNA biomarkers for bladder cancer and bladder urothelial cancer based on an ensemble model
por: Su, Qiongli, et al.
Publicado: (2022)

Relevance of myocardial injury biomarkers to the prognosis of COVID-19 patients. Response
por: Calvo-Fernández, Alicia, et al.
Publicado: (2022)

Urinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potential
por: Bryan, R T, et al.
Publicado: (2014)

Functional Genomics Profiling of Bladder Urothelial Carcinoma MicroRNAome as a Potential Biomarker()
por: Li, Wei Tse, et al.
Publicado: (2018)

Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance
por: Patnaik, M M, et al.
Publicado: (2016)

Detection of prognostically relevant mutations and translocations in myeloid sarcoma by next generation sequencing
por: Kashofer, Karl, et al.
Publicado: (2017)

Small non-coding RNA biomarkers in sputum for lung cancer diagnosis
por: Su, Yun, et al.
Publicado: (2016)

Female urethral diverticulum containing a urothelial carcinoma
por: Queiroz, Rodolfo Mendes, et al.
Publicado: (2016)

Prediction of survival in patients with upper tract urothelial carcinoma
por: Guo, Boda, et al.
Publicado: (2021)

KMT2A/C mutations function as a potential predictive biomarker for immunotherapy in solid tumors
por: Zhang, Rui, et al.
Publicado: (2020)

Appropriate Utilization of Quality of Life Outcomes in Prostate and Bladder Cancer: Practical Considerations for Brazilian Portuguese Questionnaires
por: Heldwein, Flavio L., et al.
Publicado: (2009)

Proteomic Profiling of Ectosomes Derived from Paired Urothelial Bladder Cancer and Normal Cells Reveals the Presence of Biologically-Relevant Molecules
por: Surman, Magdalena, et al.
Publicado: (2021)

Pan-cancer characterization of expression and clinical relevance of m(6)A-related tissue-elevated long non-coding RNAs
por: Xu, Kang, et al.
Publicado: (2021)

Mutational analysis of Ras hotspots in patients with urothelial carcinoma of the bladder
por: Tripathi, Kiran, et al.
Publicado: (2020)

Kinase-associated gene mutation pattern and clinical relevance in 205 patients with core binding factor leukemias
por: Chen, Y-S, et al.
Publicado: (2016)

Peripheral blood non-canonical small non-coding RNAs as novel biomarkers in lung cancer
por: Gu, Wanjun, et al.
Publicado: (2020)

Is the AED as intuitive as we think? Potential relevance of “The Sound of Silence” during AED use
por: Abelairas-Gómez, Cristian, et al.
Publicado: (2022)

Potential Biomarker for Human Uterine Leiomyosarcoma
por: Hayashi, Takuma, et al.
Publicado: (2014)

Pancancer Analysis of Neurovascular-Related NRP Family Genes as Potential Prognostic Biomarkers of Bladder Urothelial Carcinoma
por: Deng, Chao, et al.
Publicado: (2021)

Properties of non-coding mutation hotspots as urinary biomarkers for bladder cancer detection
por: Baxter, L., et al.
Publicado: (2023)

Radiomic Biomarkers as a Non-Invasive Tool for Assessing Biological Age
por: Chambers, Kevoyne H.
Publicado: (2023)

Surgical management of urothelial cancer in a cirrhotic patient after partial splenic embolisation
por: Dina, Ion, et al.
Publicado: (2019)

A plea for better coding rules for bladder cancer.
por: Schouten, L. J., et al.
Publicado: (1993)

Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression.
por: Rieger, K. M., et al.
Publicado: (1995)

Relevance of concurrent hypercalcemia in ureteric sarcoidosis complicated with bladder urothelial carcinoma: a case report
por: Hayashida, Michikata, et al.
Publicado: (2020)

Reinvestigating the clinical relevance of the m(6)A writer METTL3 in urothelial carcinoma of the bladder
por: Koch, Jonas, et al.
Publicado: (2023)

Targeting ERBB2 mutations in solid tumors: biological and clinical implications
por: Cousin, Sophie, et al.
Publicado: (2018)

Utility of aptamers for antileishmanial drug targets: A potential hypothesis
por: Keighobadi, Masoud, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rvj45ilai49uqlqsrnd6gga1ld